CT diagnosis of intrasplenic @entity3 from XXXX .

@entity43 @entity1 @entity730 @entity3
Intrasplenic metastases from @entity43 cannot be always demonstrated intraoperatively. CT is the most important imaging modality of choice for staging and follow-up @entity43 ; in this study we searched CT appearances of intrasplenic metastases from @entity43 . We retrospectively reviewed imaging histories of the @entity1 with @entity43 from the radiology information system, and found 12 @entity1 with intrasplenic @entity3 . All @entity1 underwent abdominal CT with 16-MDCT. We searched number, density and maximum diameters of splenic @entity3 . The growing rate of three lesions, which were followed up by CT, was calculated. Serum cancer antigen (CA) 125 levels were noted. We also evaluated clinical history and pathology reports of all @entity1 . Splenic metastases, solitary or multiple, were detected most frequently during the follow-up (1-14 years after initial diagnosis) and most were associated with other sites of recurrence. The diameters of lesions ranged from 4 to 85mm. All lesions appeared hypodense except for one lesion with dense @entity730 . Densities of lesions ranged from 12 to 208 Hounsfield units (mean, 49  51HU). Most lesions appeared as solid well-defined nodules; however some lesions had lobulated and irregular contours with an infiltrative pattern. The growing rates of three lesions were 0.72mm/month, 1.75mm/month and 2.70mm/month. Eight @entity1 had elevated serum CA 125 levels (40-1256U/mL). We concluded that CT can demonstrate intraparenchymal and infiltrative splenic @entity3 in @entity1 with @entity43 even in the absence of increased CA 125 levels.
